Depression and anxiety are the most common psychiatric disorders in the world. Around 300 million people suffer from ...

Her relapse into depression felt like defeat—but it offered vital clues to achieving lasting psychiatric relief. The 67-year-old woman from Alabama had already endured four major depressive episodes ...

Struggling with chronic pain and stress? Discover how combining chiropractic care with psychotherapy can create a healing ...

Prompt recognition and effective treatment of depression are of critical importance for improving the cancer patient's quality of life. Despite the efficacy of antidepressant medications, they are ...

Panelists discuss how treatment strategies differ between transplant-eligible and transplant-ineligible multiple myeloma patients, with transplant eligibility determined by functional status ...

Key takeaways: There is an urgent need to enable functional recovery in people with spinal cord injuries. The goal of NVG-291’s development is to improve neural connections in humans with SCI.

Ask fans of Lionel Messi to choose a favorite goal and you’ll elicit a dizzying range. This is to be expected. The Argentine, after all, has scored more than 860 times over his two-decade ...

Sackeim HA, et al. Characterizing the effects of vagus nerve stimulation on symptom improvement in markedly treatment-resistant major depressive disorder: A RECOVER trial report. July 1, 2025. DOI: 10 ...

Over the course of the 12-week study, the depression symptoms in all patients showed clear improvement – there was, however, no difference between those who received statins and those in the ...

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway – ALTO-207 ...

Alto’s clinical-stage pipeline includes novel drug candidates in bipolar depression, major depressive disorder, treatment resistant depression (TRD), and schizophrenia, and other mental health ...